Because GIV is required for the protective effects of MDP/NOD2 signaling in DSS-induced colitis (Figure 5, A–E), we next asked whether this protection arises from MDP’s ability to promote early induction of niCoIAMs, thereby accelerating recovery from acute colitis. Here, NOD2 is linked to colitis.